Colostrum: The Forgotten Immune & Gut Superfood — A Pharmacist’s Evidence Review

Khang Pharmacy Mascot

Dai Tran, PharmD, MBA, B.S.

CEO & Lead Pharmacist, Khang Pharmacy • CA/MN/TX Licensed Pharmacist

Clinical Insights Series • APhA Immunization Certified • 10+ Years Clinical Experience

What Is Colostrum?

Colostrum is the first milk produced by mammals in the days immediately following birth — before regular milk production begins. It is nature’s most concentrated delivery of immune factors, growth factors, and gut-protective compounds, designed to rapidly establish the newborn’s immune system and seal the intestinal barrier.

Bovine colostrum (from cows) is remarkably similar in composition to human colostrum — and in some respects more concentrated. It has been used medicinally for centuries and has accumulated a substantial modern clinical evidence base over the past three decades.

Evidence Transparency Note: The studies cited in this article evaluated various bovine colostrum preparations at doses and concentrations that differ from the NanoPro PRP™ finished product (2g colostrum per serving). Some studies used hyperimmune or specialized colostrum products not equivalent to standard commercial colostrum. Colostrinin™ studies used an ovine (sheep)-derived PRP extract — not bovine colostrum and not NanoPro PRP™. Ingredient-level findings should not be interpreted as direct evidence of finished-product efficacy.

Key Bioactive Components of Colostrum

  • Proline-Rich Polypeptides (PRPs): Immunologically active signaling peptides that influence immune function. PRPs demonstrate immunoregulatory activity in experimental research involving innate and adaptive immune signaling and cytokine production. Whether this translates into clinically meaningful immune “balancing” in humans remains under investigation.
  • Immunoglobulins (IgG, IgA, IgM): Bovine colostrum contains substantially higher concentrations of immunoglobulins than mature cow’s milk, particularly IgG, although concentrations vary widely by animal, timing of collection, and processing.
  • Lactoferrin: An iron-binding glycoprotein with antimicrobial and anti-inflammatory properties. Lactoferrin has broad antiviral activity in experimental research; human studies suggest possible effects on respiratory-tract infection outcomes, particularly in children, but pathogen-specific clinical efficacy against influenza or RSV is not firmly established.
  • Insulin-like Growth Factor 1 (IGF-1): Colostrum contains IGF-1, which has roles in gut epithelial cell proliferation and tissue repair. However, human supplementation studies have not consistently increased circulating IGF-1 levels; IGF-1 has not been established as the clinical mediator of colostrum’s performance or gut effects.
  • Growth-related peptides and hormones are naturally present in colostrum, but their contribution to clinical outcomes after oral supplementation in adults is not established.
  • Lysozyme: An antimicrobial enzyme that disrupts bacterial cell walls.
  • Cytokines: Immune signaling molecules including IL-1, IL-6, TNF-α, and interferons that prime immune responses.

What Does the Clinical Evidence Show?

Evidence labels: HUMAN RCT  |  META-ANALYSIS  |  MECHANISTIC / PRECLINICAL

Gut Health & Intestinal Permeability

Important distinction: Human trials support selected bovine-colostrum preparations for acute infectious diarrhea, particularly rotavirus in children. Several studies used hyperimmune colostrum or concentrated immunoglobulin products — not standard commercial colostrum. Evidence for Cryptosporidium is limited and primarily involves hyperimmune products in immunocompromised populations. Grade: SUPPORTED for rotavirus/selected populations; LIMITED for Cryptosporidium.

  • HUMAN RCT PMID 30551120 — Critically ill ICU patients: Randomized double-blind placebo-controlled trial in 70 adults; enteral bovine colostrum significantly reduced zonulin, reduced endotoxin by day 10, and lowered diarrhea incidence. Supports improved intestinal-permeability biomarkers and reduced gastrointestinal complications in critically ill patients; authors noted the need for further research.

Note: The chemotherapy intestinal-damage claim has been removed pending identification of a specific qualifying human RCT. Grade for ICU: SUPPORTED / LIMITED RCT.

Immune Support

  • HUMAN RCT PMID 24200515 — URTI in active adults: Randomized trial in 53 active men; 20 g/day colostrum for 12 weeks found significantly fewer upper-respiratory illness days and episodes in the colostrum group. Conventional immune markers (salivary IgA, neutrophil oxidative burst) did not significantly improve. Human RCTs in physically active adults have reported fewer upper-respiratory illness episodes and symptom days during bovine-colostrum supplementation; some studies report reductions approaching 40–50%, although laboratory-confirmed infection prevention has not been established. Grade: SUPPORTED / MODERATE.
  • MECHANISTIC PMID 17499201, PMID 19939229 — PRP immunoregulatory activity: PRPs have demonstrated immunoregulatory activity in experimental systems, including effects on innate and adaptive immune signaling and cytokine production (IFN, TNF-α, IL-6, IL-10). Whether this translates into clinically meaningful immune “balancing” in humans remains uncertain. Grade: MECHANISTICALLY SUPPORTED / NOT CLINICALLY ESTABLISHED.
  • LIMITED HUMAN EVIDENCE PMID 35481594 — Lactoferrin and respiratory infections (2022 meta-analysis): Lactoferrin has broad antiviral activity in experimental research. A 2022 systematic review/meta-analysis found lactoferrin reduced some respiratory-tract-infection outcomes, especially in infants and children, but adult RTI incidence was not significantly reduced overall. Pathogen-specific clinical efficacy against influenza or RSV is not firmly established in human RCTs. Grade: LIMITED / PRECLINICAL-TO-MIXED.

Athletic Performance

  • HUMAN RCT PMID 12500989 — Sprint performance in elite athletes: In 35 elite field-hockey players, 60 g/day bovine colostrum for 8 weeks significantly improved repeated sprint performance versus whey protein. Body composition did not differ significantly between groups.
  • HUMAN RCT PMID 11312068 — Lean body mass in active adults: In active men and women, 20 g/day bovine colostrum for 8 weeks increased bone-free lean body mass (~1.49 kg) compared with baseline. Other performance measures did not significantly differ. Note: this is a separate study from the sprint trial above and used a different dose and population.
  • HUMAN RCT / META-ANALYSIS PMID 21148400 — Exercise-induced gut permeability: Double-blind crossover study; exercise increased gut permeability 2.5-fold during placebo; colostrum attenuated the increase by approximately 80%. A 2024 meta-analysis (PMID 38361147) supports an overall beneficial signal for intestinal-permeability markers. However, contradictory findings exist: PMID 22253980 found permeability increased more after colostrum than control in some conditions; PMID 25068884 found no observable benefit during exercise in heat. Grade: MODERATE / MIXED-SUPPORTIVE.
  • MECHANISTIC PMID 12188088 — IGF-1 and recovery: Bovine colostrum contains IGF-1, but human supplementation studies have not consistently increased circulating IGF-1 levels. In this study, plasma IGF-1 did not significantly differ between groups after 60 g/day for 8 weeks, yet second-bout running performance improved — suggesting some recovery benefit through a mechanism not established as IGF-1-mediated. Grade: MECHANISTICALLY PLAUSIBLE / IGF-1 NOT ESTABLISHED AS CLINICAL MEDIATOR.

Cognitive Health (Emerging) — Important Product Firewall

Critical distinction: The cognitive studies below used Colostrinin™ — a proprietary PRP complex isolated from ovine (sheep) colostrum. Colostrinin™ is not bovine colostrum and is not NanoPro PRP™. These findings cannot be presented as evidence that NanoPro PRP™ improves cognition.

Grade: PRELIMINARY HUMAN SUPPORT for Colostrinin (ovine PRP extract) in mild-to-moderate Alzheimer’s disease. This evidence does not apply to bovine colostrum or NanoPro PRP™.

  • MECHANISTIC / PRECLINICAL PMID 19939229 — PRP neuroinflammation and amyloid-beta: PRP/Colostrinin has demonstrated effects on inflammatory signaling and amyloid-beta aggregation and disruption of existing aggregates in experimental research. Whether these mechanisms explain clinical cognitive effects remains uncertain. Grade: PRECLINICAL / MECHANISTIC SUPPORT.

Featured Product: BioPharma Scientific NanoPro PRP™ Vanilla

NanoPro PRP Vanilla

BioPharma Scientific NanoPro PRP™ Vanilla (540g)

12g whey protein isolate per serving • 2g Colostrum with PRPs • 50mg Reduced L-Glutathione • Lactase enzyme (low lactose) • NanoSorb™ delivery technology. Stevia-sweetened.

PharmD note: NanoPro PRP™ combines whey protein isolate with bovine colostrum PRPs and reduced glutathione in a single daily serving. NanoSorb™ is described by the manufacturer as a delivery technology intended to improve bioavailability; independent pharmacokinetic validation of this specific product is not available. The clinical studies cited in this article evaluated colostrum at doses and formulations different from this product; ingredient-level evidence should not be extrapolated to finished-product efficacy claims. Patients on warfarin, immunosuppressants, or glucose-lowering medications should consult their pharmacist before use.

Colostrum vs Whey Protein: What’s the Difference?

Feature Colostrum Whey Protein
Primary benefit Immune modulation, gut barrier support Muscle protein synthesis
Key compounds PRPs, IgG, lactoferrin, IGF-1 BCAAs, leucine, complete amino acids
Gut support Studied for permeability and gastrointestinal resilience Moderate — supports gut microbiome
Best combined with Whey protein (as in NanoPro PRP) Colostrum for immune + gut benefits

Who May Benefit from Colostrum Supplementation

  • Athletes in heavy training — human RCTs support reduced exercise-induced gut permeability and upper-respiratory illness episodes
  • Patients with gut permeability concerns — NSAID-associated and ICU permeability evidence is supportive
  • Adults with frequent upper-respiratory illness during training or periods of immune stress — URTI evidence in active adults is promising; clinical infection prevention has not been laboratory-confirmed
  • Older adults interested in immune-health support — limited human evidence suggests effects on selected inflammatory biomarkers; clinical infection-prevention benefit has not been established
  • Dairy allergy: Colostrum is dairy-derived — contraindicated in true dairy allergy

Drug Interactions — What Pharmacists Need You to Know

  • Immunosuppressants: Colostrum’s immune-influencing properties may theoretically interact with immunosuppressive medications. Transplant patients should consult their physician before use.
  • Diabetes medications: No well-established clinically significant interaction has been demonstrated between colostrum supplementation and insulin or oral glucose-lowering agents. Patients using insulin or other glucose-lowering therapies should review all supplements with their pharmacist, particularly if glucose control changes.
  • Dairy allergy / lactose intolerance: NanoPro PRP contains whey and colostrum (dairy-derived). Lactase enzyme is included to reduce lactose content, but patients with severe dairy allergy should avoid.
  • Soy allergy: NanoPro PRP contains soy — check label if soy-allergic.

Evidence Summary

Evidence Ratings (ingredient-level, human data):
NSAID-induced gut permeability — SUPPORTED
Rotavirus diarrhea (selected/hyperimmune preparations) — SUPPORTED
Cryptosporidium diarrhea — LIMITED / SPECIALIZED POPULATIONS
ICU intestinal permeability and GI complications — SUPPORTED / LIMITED RCT
Chemotherapy intestinal damage — INSUFFICIENT HUMAN EVIDENCE — REMOVED
URTI reduction in active adults — SUPPORTED / MODERATE
PRP immune modulation — MECHANISTICALLY SUPPORTED / NOT CLINICALLY ESTABLISHED
Lactoferrin antiviral efficacy (influenza/RSV) — LIMITED / PRECLINICAL-TO-MIXED
Sprint performance (60 g/day, elite athletes) — SUPPORTED — PMID 12500989
Lean body mass (20 g/day, active adults) — SUPPORTED — PMID 11312068 (separate study)
Exercise-induced gut permeability — MODERATE / MIXED-SUPPORTIVE
IGF-1 as muscle/recovery mediator — NOT ESTABLISHED IN HUMANS
Colostrinin/Alzheimer’s (ovine PRP) — PRELIMINARY HUMAN SUPPORT — does not apply to NanoPro PRP™
PRP neuroinflammation/Aβ mechanism — PRECLINICAL / MECHANISTIC
NanoPro PRP™ finished-product clinical efficacy — NOT DIRECTLY ESTABLISHED

Pharmacist’s Bottom Line

As a PharmD, I discuss colostrum with patients who have gut permeability concerns, frequent upper-respiratory illness during heavy training, or interest in immune resilience. The strongest human evidence supports selected bovine colostrum preparations for NSAID-induced gut permeability, rotavirus diarrhea in children, ICU gastrointestinal complications, and upper-respiratory illness in active adults. Athletic performance data — particularly for sprint performance and lean mass — is promising but comes from studies using doses (20–60 g/day) substantially higher than NanoPro PRP™’s 2 g per serving; an evidence-based daily dose for general immune support has not been established. The Colostrinin/Alzheimer’s data is intriguing but involves an ovine-derived PRP product not equivalent to NanoPro PRP™.

Free PharmD consultation available: (408) 622-8068.

Frequently Asked Questions

Q: Is bovine colostrum safe for humans?
A: Bovine colostrum has generally been well tolerated in published clinical studies, but it should be avoided by individuals with a true cow’s-milk protein allergy.

Q: How much colostrum do I need daily?
A: Clinical studies have used 20–60 g/day of whole colostrum powder. NanoPro PRP provides 2 g of colostrum with PRPs per serving. This is lower than most adult clinical-trial doses, and an evidence-based “maintenance dose” for general immune support has not been established.

Q: Can I take colostrum if I’m lactose intolerant?
A: NanoPro PRP contains dairy-derived whey and colostrum and includes lactase enzyme. Lactose content and individual tolerance can vary. People with lactose intolerance should assess tolerance individually; those with a true milk-protein allergy should avoid the product.

Q: Is colostrum ethical / sustainable?
A: Bovine colostrum is collected from surplus produced after the calf’s needs are met. Reputable manufacturers ensure calves receive adequate colostrum before any is collected for supplements.

Related Clinical Insights Articles


FDA Disclaimer

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Colostrum is a dietary supplement. The information provided is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Khang Pharmacy Mascot

Reviewed by:

Dai Tran, PharmD, MBA, B.S.View full bio →

CEO & Lead Pharmacist, Khang Pharmacy • CA/MN/TX Licensed • 10+ Years Clinical Experience

Khang Pharmacy | 2451 S King Rd., Ste A1, San Jose, CA 95122 | (408) 622-8068 | www.khangpharmacy.com